Altimmune, Inc.ALTNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank43
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-4.71
Near historical average
Percentile
P43
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-4.81
Historical baseline
PeriodValueYoY Change
2025-4.71+26.6%
2024-6.41+18.8%
2023-7.90+35.8%
2022-12.31-194.7%
2021-4.18+50.0%
2020-8.35-223.1%
2019-2.58-365.6%
2018-0.55+55.6%
2017-1.25-920.9%
20160.15-